GENEVA, Oct. 5 -- DANA-FARBER CANCER INSTITUTE, INC. filed a patent application (IB2026/053075) for “COMPOSITIONS AND TREATMENT OF HER2 HETEROGENOUS, HER2-LOW, OR HER2 THERAPY-RESISTANT CANCERS”. With publication no. WO/2026/202862, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 31/195
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....